Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8ffdd0403966b3257cdff37810d77910 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C237-30 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-00 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C229-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C237-30 |
filingDate |
2004-12-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0ce4396c10dd2c46f7345e923430ca70 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c108785a4b3f9daa219564b6f77fbfc7 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e50c488a77b524e61303de0f6fbbec9f |
publicationDate |
2007-10-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
EP-1697300-A4 |
titleOfInvention |
BONE TISSUE TARGETING COMPOUNDS FOR ADMINISTRATION TO BONE OF CON US AGENTS FOR INTERACTING WITH BONE |
abstract |
The present invention relates to compounds of the formula, or pharmaceutically acceptable salts thereof, useful for delivering agents having the capacity to diagnose, treat or prevent bone injury or disease to the bone for interaction therewith. |
priorityDate |
2003-12-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |